Anonymous
Guest
Anonymous
Guest
THV is an important bet, but what about other initiatives, for example in HVT, Critical Care or emerging markets, and their successful execution to mitigate the THV risks?
Listening to this week’s earnings call, the management does not appear to be showing a balanced strategy and its robust implementation. It looks like the company may have some fundamental challenges beneath the surface.
With this significant market cap decline, it may become a takeover target. Any thoughts or comments?
Listening to this week’s earnings call, the management does not appear to be showing a balanced strategy and its robust implementation. It looks like the company may have some fundamental challenges beneath the surface.
With this significant market cap decline, it may become a takeover target. Any thoughts or comments?